Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in increased expression of DLK1 mRNA | increases expression | 19933214
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of DLK1 mRNA | affects expression | 20406850
|
C006632 |
arsenic trioxide |
DLK1 protein affects the susceptibility to arsenic trioxide | affects response to substance | 18575777
|
D001374 |
Azacitidine |
Azacitidine results in decreased methylation of DLK1 promoter | decreases methylation | 19194470
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DLK1 mRNA | decreases expression | 20106945
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of DLK1 mRNA | decreases expression | 20127859
|
C014347 |
decitabine |
decitabine results in decreased methylation of DLK1 promoter | decreases methylation | 19194470
|
C014347 |
decitabine |
decitabine results in increased expression of DLK1 mRNA | increases expression | 19194470
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of DLK1 mRNA | decreases expression | 17557909
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of DLK1 mRNA | increases expression | 18035473
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of DLK1 mRNA | increases expression | 17187413 15567716 17538966
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of DLK1 protein | increases expression | 17538966
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of DLK1 mRNA] | affects reaction|decreases expression | 15016801
|
D019833 |
Genistein |
Genistein results in increased expression of DLK1 mRNA | increases expression | 18359623
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in decreased expression of DLK1 mRNA | decreases expression | 12057914
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of DLK1 mRNA | decreases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DLK1 mRNA | increases expression | 19933214
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of DLK1 mRNA | decreases expression | 16012519
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of DLK1 mRNA | increases expression | 16604517
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 14514962 15322242 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.04 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
4.09 | 18653653 11850527 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
13.70 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
13.70 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
13.70 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
13.70 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
13.70 | 11473722 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
7.06 | 10737359 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
7.06 | 6695378 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
6.11 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.46 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.66 | 15955085 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.85 | 15504547 16511603 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.85 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
marker/mechanism |
|
| 18575777 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.54 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.31 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.31 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.27 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.47 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
15.67 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
15.67 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
15.67 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.98 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.98 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.98 | 15136595 16110121 19217205 18357371 16595493 18608205 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.98 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.98 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.98 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.67 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.39 | 11589617 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.76 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.33 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.33 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.26 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
11.52 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
11.52 | 17761372 6705139 3084413 10737359 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
11.52 | 15073043 11135700 14691202 15553829 16217749 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
11.52 | 17045692 18930000 16332177 16799960 17971768 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
11.52 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
11.52 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.97 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.04 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.17 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.93 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
10.93 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
10.93 | 17066447 16757204 16280240 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.93 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.34 | 16332659 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.12 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.81 | 6135515 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.67 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.91 | 17681005 15861022 16919318 17333356 11677210 17110522 16105132 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.26 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.83 | 8697196 15340226 12621046 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.83 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.78 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
5.95 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
5.95 | 17725105 18772588 17018589 16510598 17172411 15001691 17016597 17169374 17287894 16340194 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
5.95 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
4.88 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
4.88 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.88 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
4.88 | 15148649 16524972 18509181 16391804 17401013 20501625 16303861 17695437 18383874 18288408 17594712 14970324 15289873 17255274 16282729 18448328 17454858 17094418 17016601 18949393 18802399 16331619 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.25 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.79 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.79 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.79 | 9224671 8800419 9211117 17551590 16925845 10589399 9142499 9664655 14991402 9125849 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.09 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.87 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.15 | 15213294 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.37 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.37 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.75 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.75 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.27 | 16714409 15322242 18230668 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.27 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.25 | 12538720 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.21 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.67 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
7.67 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.67 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.48 | 15328337 15821434 17637181 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
7.34 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
7.34 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.34 | 15173087 17638652 16337965 16481741 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.97 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.97 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.92 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.92 | 15345470 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
4.06 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.86 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.86 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.33 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
7.32 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.32 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.89 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
13.18 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
13.18 | 15102660 15162350 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
13.18 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.26 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.25 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.25 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.25 | 9664655 14991402 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
5.41 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
4.46 | 6705139 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.43 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 16354765 18606429 16959395 15340226 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.25 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.64 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.92 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.88 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.52 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.84 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.84 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.53 | 17296493 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
8.53 | 9205823 17963957 12878042 17237260 17255318 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.53 | 12200463 12878042 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.84 | 17994277 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.69 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.12 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.12 | 15992940 17551590 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.63 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
7.63 | 16985049 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
19.99 | 15070760 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
19.99 | 19148494 |
MESH:D007938 |
Leukemia |
|
decitabine |
19.99 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Genistein |
19.99 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
19.99 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.85 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.39 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.47 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
23.32 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
23.32 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
23.32 | 19117987 18454857 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
23.32 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
8.90 | 20471514 19850784 16467208 17050201 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
8.90 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
8.90 | 17679729 18704418 19010910 19387464 18460780 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
8.90 | 19850784 16294345 17596541 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.56 | 18055864 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
5.25 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.75 | 15622746 17649720 12018890 19035177 16331271 19642359 17869043 16823087 12712474 16112521 15336539 17712046 16330433 11468182 15748426 9834237 12679006 17107899 17217047 16891316 16966277 19075265 19225113 15213294 11161223 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.75 | 19029980 16891316 12679006 19075265 19035177 17506722 16331271 17107899 16766008 16823087 19642359 17294898 17301526 17339181 16935935 17361223 16140955 16788101 17368321 9834237 17217047 17649720 19225113 17712046 15748426 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.42 | 16882451 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.78 | 15821434 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.34 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
5.03 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
5.03 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.03 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
5.03 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
18.26 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
18.26 | 10672840 10737359 18001218 14678523 16273603 11376686 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
18.26 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
18.26 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
18.26 | 15113037 16603448 18383874 17045692 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
18.26 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.43 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
14.43 | 6150874 1399818 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.43 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.43 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.39 | 15213294 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
4.08 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
8.65 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
8.65 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
8.65 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
8.65 | 20869020 6695378 18816296 20064080 18569708 20464547 18520028 17053015 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
8.65 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
8.65 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.87 | 15086387 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.46 | 19470736 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
2.97 | 14578162 12929590 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.80 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.45 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.45 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.50 | 16940565 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
6.18 | 19299654 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.67 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.67 | 16757204 18986760 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
12.48 | 19417148 15949261 14977855 11468182 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
12.48 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
12.48 | 18172295 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.77 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
marker/mechanism |
|
| 18575777 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
17.86 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
17.86 | 19805378 17596541 17611569 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
17.86 | 18608210 19010910 19157545 16882708 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
17.86 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.88 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.06 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
3.70 | 17141266 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.94 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.02 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
12.10 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
12.10 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
12.10 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
12.10 | 16946489 16594593 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
16.78 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
16.78 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
16.78 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.42 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.42 | 9142499 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.47 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.48 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
3.28 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.14 | 16169203 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
11.46 | 19769630 12452020 16624393 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
11.46 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
11.46 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.46 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.95 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
12.51 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
12.51 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
12.51 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.51 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.75 | 11578682 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.22 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.64 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11118676 11896295 11222880 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.80 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.88 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
1.88 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.88 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.88 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
1.88 | 15378649 15256057 16925846 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.66 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.39 | 15861022 16919318 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.88 | 16723453 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.06 | 16160472 15538739 18722050 18286688 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.76 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
11.15 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
11.15 | 16116481 16283617 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.02 | 16646077 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.57 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.53 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.53 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.53 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.04 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
6.46 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
6.46 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
6.46 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
6.46 | 16424979 16951190 17172411 19015929 17522103 17498489 19084572 18567086 15786421 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
6.46 | 17261132 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.21 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.68 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.20 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
12.27 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
12.27 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
12.27 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
10.00 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
10.00 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.04 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.26 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
16.04 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
16.04 | 15289314 1399818 15867355 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
16.04 | 11780464 20435036 12845720 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
16.04 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
16.04 | 19087683 17616700 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.40 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.62 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.62 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.36 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
13.16 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
13.16 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.59 | 15869587 14671159 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.12 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.02 | 16287080 |